Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1985 | 1 |
1990 | 1 |
1997 | 1 |
1999 | 2 |
2001 | 1 |
2002 | 1 |
2003 | 1 |
2005 | 1 |
2006 | 1 |
2010 | 1 |
2012 | 2 |
2013 | 1 |
2015 | 2 |
2017 | 1 |
2019 | 1 |
2020 | 3 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
23 results
Results by year
Twice daily administration of [A14K]PGLa-AM1 (75 nmol/kg body weight) for 28 days significantly (P < 0.05) decreased circulating blood glucose and HbA1c and increased plasma insulin concentrations leading to improvements in glucose tolerance. ...Elevate
…Twice daily administration of [A14K]PGLa-AM1 (75 nmol/kg body weight) for 28 days significantly (P < 0.05) decreased circulating
…Serum PC (16:1/22:6) levels were negatively correlated with circulating alanine transaminase (ALT) (r = -0.268, p = 0.021), triacylglycerol (TAG) (r = -0.236, p = 0.042), interleukin (IL)-1beta (r = -0.401, p < 0.001) and tumor necrosis factor (TNF)-alpha
…